Loss of function and p53 protein stabilization (original) (raw)
- Review
- Published: 16 October 1997
Oncogene volume 15, pages 1889–1893 (1997)Cite this article
- 1739 Accesses
- 7 Altmetric
- Metrics details
Abstract
Wild-type (wt) p53 protein is rapidly degraded, has a short half-life and low intracellular levels. Stabilization of wt p53 protein following an appropriate stimulus (for example DNA damage) is a physiological regulation to increase function. In contrast, stabilization of p53 protein in the absence of a stimulus is always a hallmark of loss of function secondary to a mutation, or interaction with viral or cellular oncoproteins. It is generally accepted that stability of p53 protein depends on its intrinsic biochemical properties such as conformation or protein/protein interactions. However, I will discuss evidence that the stability of p53 is not a consequence of its intrinsic properties, but instead is determined by feedback control of its function. In the absence of an appropriate stimulus, a cell needs to keep p53 levels low, since increased levels can lead to apoptosis. To precisely regulate p53 levels, a cell must sense its level; and sensing its transactivating function, is the simplest way to sense p53. Following an appropriate stimulus (for example, DNA damage), the cell senses a state of 'relative' p53 deficiency and adapts by reducing p53 degradation. When the state of p53 deficiency is a consequence of a mutation or interaction with viral oncoproteins, the cell does not sense p53, and again attempts to adapt by reducing p53 degradation. However, in the latter case, the increase in levels does not restore function, and the adaptation continues until degradation of p53 protein is maximally inhibited. In this case, no further inhibition of degradation is possible after DNA-damage or pharmacological inhibition of proteasomes. Thus lack of wt p53 function always results in increased p53 levels and nonregulation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Medicine Branch, National Cancer Institute, NIH, Bethesda, 20892, Maryland, USA
Mikhail V Blagosklonny
Authors
- Mikhail V Blagosklonny
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Blagosklonny, M. Loss of function and p53 protein stabilization.Oncogene 15, 1889–1893 (1997). https://doi.org/10.1038/sj.onc.1201374
- Received: 17 April 1997
- Revised: 20 June 1997
- Accepted: 25 June 1997
- Issue Date: 16 October 1997
- DOI: https://doi.org/10.1038/sj.onc.1201374